The Mycoplasma Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Mycoplasma Testing Market?
The mycoplasma testing market has experienced quick expansion lately. The market size is set to increase from $1.08 billion in 2024 to $1.23 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Mycoplasma Testing Industry?
The Mycoplasma Testing Global Market is projected to reach $1.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.7%.
Download Your Free Sample of the 2025 Mycoplasma Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Mycoplasma Testing Market?
The key drivers in the mycoplasma testing market are:
• Increased demand for quality assurance in testing
• Growth of biopharmaceutical industry and rise in cell-based therapies
• Expansion in biotechnology sector and emergence of new markets
• Innovation in point-of-care testing and improved global pandemic preparedness
Global Market Segmentation: Identifying Major Mycoplasma Testing Industry Segments
The mycoplasma testing market covered in this report is segmented –
1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes
Pre-order the 2025 Mycoplasma Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Mycoplasma Testing Market?
The key trends in the mycoplasma testing market are:
• Regulatory standards and compliance form a major trending influence in the market.
• Increased healthcare awareness and advancements in diagnostics are shaping the future of the market.
• The readiness and response to global pandemics represent a significant emerging trend.
• Innovation in point-of-care testing and market expansion in emerging economies are influential trends.
Who Are the Top Competitors & Leading Players in the Mycoplasma Testing Market?
Major companies in the mycoplasma testing market are:
• Abbott Laboratories
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Lonza Group AG
• Roche Diagnostics International AG
• Charles River Laboratories International Inc.
• Nelson Laboratories Fairfield Inc.
• Creative Bioarray
• Biological Industries Israel Beit Haemek Ltd.
• Biotools B & M Labs S.A
• PromoCell GmbH
• American Type Culture Collection
• Bionique Testing Laboratories Inc.
• InvivoGen
• Clongen Laboratories LLC
• Norgen Biotek Corporation
• Gen Bio Sciences (P) Ltd.
• GeneCopoeia Inc.
• Minerva Biolabs GmbH
• Mycoplasma Experience
• Savyon Diagnostics
• ScienCell Research Laboratories Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the mycoplasma testing market in 2024
